Rodríguez-Florido Marco Antonio, Feria-Romero Iris A, Nettel-Rueda Bárbara, Guerrero-Cantera José, Orozco-Suárez Sandra, Chavez Jesús A, Guinto Gerardo, Grijalva Israel
Unit of Medical Research in Neurological Diseases, Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Mexico City, Mexico.
Specialty Hospital, Department of Neurosurgery. Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Mexico City, Mexico.
Gac Med Mex. 2019;155(5):439-446. doi: 10.24875/GMM.M20000329.
Gliomas are neoplasms with high recurrence and mortality. Due to the difficulty to apply the World Health Organization (2016) classification, developing countries continue to use histological evaluation to diagnose and classify these neoplasms.
To develop a semi-quantitative scale to numerically grade gliomas by its morphological characteristics.
A cohort of patients with gliomas was assessed and followed for 36 months. Tumor tissue sections were analyzed and graded, including aspects such as cell line, cellularity, nuclear pleomorphism, mitosis, endothelial hyperplasia, hypoxic changes, apoptotic bodies, necrosis, hemorrhage and proliferation index.
58 cases were analyzed. Low-grade gliomas median score was 12 points (9 and 13.5 for percentiles 25 and 75, respectively), whereas for high-grade gliomas it was 17 points (16 and 20.5 for percentiles 25 and 75, respectively) (p < 0.0001). Thirty-six-month survival of patients with low (13/17) and high grade gliomas (6/41) was also significantly different (p < 0.0001).
The semi-quantitative morphological scale allows an objective evaluation of gliomas, with an adequate correlation between the score, tumor grade and survival time.
胶质瘤是具有高复发率和死亡率的肿瘤。由于应用世界卫生组织(2016年)分类存在困难,发展中国家继续使用组织学评估来诊断和分类这些肿瘤。
制定一种半定量量表,根据胶质瘤的形态学特征对其进行数字分级。
对一组胶质瘤患者进行评估并随访36个月。分析肿瘤组织切片并分级,包括细胞系、细胞密度、核多形性、有丝分裂、内皮细胞增生、缺氧变化、凋亡小体、坏死、出血和增殖指数等方面。
分析了58例病例。低级别胶质瘤的中位评分为12分(第25和第75百分位数分别为9分和13.5分),而高级别胶质瘤为17分(第25和第75百分位数分别为16分和20.5分)(p<0.0001)。低级别(13/17)和高级别胶质瘤(6/41)患者的36个月生存率也有显著差异(p<0.0001)。
半定量形态学量表能够对胶质瘤进行客观评估,评分、肿瘤分级和生存时间之间具有良好的相关性。